Nobiletin Inhibits Hypoxia-Induced Placental Damage via Modulating P53 Signaling Pathway

Nutrients. 2022 Jun 1;14(11):2332. doi: 10.3390/nu14112332.

Abstract

In this study, we aimed to evaluate the effect of Nobiletin (NOB) on the placenta of Sprague-Dawley (SD) rats that had undergone reduced uterine perfusion pressure (RUPP) surgery and to evaluate the safety of NOB intervention during pregnancy. The results showed that NOB alleviated placental hypoxia, attenuated placental cell apoptosis, and inhibited placental damage in RUPP rats. No side effect of NOB intervention during pregnancy was observed. BeWo cell lines with P53 knockdown were then constructed using lentiviral transfection, and the P53 signaling pathway was found to be essential for NOB to reduce hypoxia-induced apoptosis of the BeWo cell lines. In summary, NOB attenuated hypoxia-induced placental damage by regulating the P53 signaling pathway, and those findings may contribute some insights into the role of NOB in placental development and the prevention of placental-related diseases.

Keywords: Nobiletin; P53 signaling pathway; RUPP; hypoxia; placenta.

MeSH terms

  • Animals
  • Female
  • Flavones
  • Humans
  • Hypoxia / drug therapy
  • Hypoxia / metabolism
  • Ischemia / drug therapy
  • Ischemia / metabolism
  • Placenta* / metabolism
  • Pre-Eclampsia* / prevention & control
  • Pregnancy
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Flavones
  • Tumor Suppressor Protein p53
  • nobiletin